findmyKOL

Directory

KOLs working with Pharmacyclics An Abbvie

21 key opinion leaders with clinical trial sponsorships or reported industry payments from Pharmacyclics An Abbvie. Relationships are drawn from ClinicalTrials.gov sponsor records and CMS Open Payments, with every number cited to its source.

Profiles

David Spigel, MD

Sarah Cannon Research Institute

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLungMedical OncologySoutheast · TN
909
publications
99
h-index
39
trials
View profile →

Howard Burris, MD

Sarah Cannon Research Institute

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLungMedical OncologySoutheast · TN
1,155
publications
117
h-index
27
trials
View profile →

Julie Vose, MD

University of Nebraska Medical Center

Active 2025
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLymphomaHematology / OncologyMidwest · NE
903
publications
111
h-index
32
trials
View profile →

Ian Flinn, MD

Tennessee Oncology

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLeukemiaHematology / OncologySoutheast · TN
933
publications
96
h-index
19
trials
View profile →

Robert Orlowski, MD

The University of Texas MD Anderson Cancer Center

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileMyelomaHematology / OncologySouth Central · TX
1,164
publications
102
h-index
10
trials
View profile →

Rafael Fonseca, MD

Mayo Clinic

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileMyelomaHematologyWest · AZ
894
publications
121
h-index
3
trials
View profile →

Bruce Cheson, MD

The Center for Cancer and Blood Disorders

Active 2025
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLymphomaHematologyNortheast · MD
655
publications
89
h-index
5
trials
View profile →

Andrew Zelenetz, MD

Memorial Sloan Kettering Cancer Center

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLymphomaMedical OncologyNortheast · NY
760
publications
98
h-index
9
trials
View profile →

David Siegel, MD

John Theurer Cancer Center

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileMyelomaMedical OncologyNortheast · NJ
699
publications
83
h-index
9
trials
View profile →

Christopher Flowers, MD

The University of Texas MD Anderson Cancer Center

Active 2026
Enriched profileLymphomaHematology / OncologySouth Central · TX
1,171
publications
83
h-index
4
trials
View profile →

Stephen Schuster, MD

Perelman School of Medicine at the University of Pennsylvania

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLymphomaHematology / OncologyNortheast · PA
804
publications
77
h-index
11
trials
View profile →

Richard Furman, MD

Weill Cornell Medicine

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLeukemiaHematologyNortheast · NY
506
publications
76
h-index
4
trials
View profile →

Brad Kahl, MD

Washington University School of Medicine in St. Louis

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLymphomaMedical OncologyMidwest · MO
906
publications
74
h-index
18
trials
View profile →

Paul Barr, MD

University of Rochester Medical Center

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileHematologyHematologyNortheast · NY
837
publications
55
h-index
25
trials
View profile →

Jesus Berdeja, MD

Sarah Cannon Research Institute

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLeukemiaHematology / OncologySoutheast · TN
531
publications
59
h-index
11
trials
View profile →

Matthew Davids, MD

Dana-Farber Cancer Institute

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLeukemiaHematology / OncologyNortheast · MA
653
publications
61
h-index
9
trials
View profile →

Charalambos Andreadis, MD

University of California, San Francisco (UCSF)

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLymphomaMedical OncologyNortheast · PA
304
publications
43
h-index
7
trials
View profile →

Alex Herrera, MD

City of Hope National Medical Center

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileHematologyHematologyWest · CA
564
publications
47
h-index
14
trials
View profile →

Jonathon Cohen, MD

Winship Cancer Institute

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLymphomaHematology / OncologySoutheast · GA
448
publications
44
h-index
11
trials
View profile →

Ibrahim Aldoss, MD

City of Hope National Medical Center

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLeukemiaHematologyWest · CA
562
publications
49
h-index
15
trials
View profile →

Alexey Danilov, MD

City of Hope National Medical Center

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileHematologyHematologyWest · CA
632
publications
41
h-index
14
trials
View profile →

Filter, sort, and export all 21 working with Pharmacyclics An Abbvie in the directory